AR036196A1
(es )
2004-08-18
Agentes de contraste multimericos dirigidos a base de peptidos
CY1107051T1
(el )
2012-10-24
Αντι-διηθητικα και αντι-αγγειογενετικα θραυσματα ουροκινασης και η χρηση τους
EP1548028A4
(de )
2006-03-15
Substituierte wt1-peptide
ATE254630T1
(de )
2003-12-15
Cyclosporine
FR06C0032I2
(fr )
2007-04-27
Formulations proteiniques
DK1079849T3
(da )
2002-04-22
Anvendelse af HMG-proteiner til fremstilling af lægemidler med cytotoksisk virkning
DK1515745T3
(da )
2009-07-13
Anvendelse af forbindelser med biologiskaktivitet af vasoaktivt intestinalt peptid til behandlingen af sarkoidose
DK1641820T3
(da )
2008-09-15
Fra RasGap afledt peptid til selektiv at dræbe kræftceller
JPS58116443A
(ja )
1983-07-11
新規ペプチドおよびその製法
WO2001085777A3
(en )
2002-03-07
Therapeutic pore-forming peptides
NO20026147L
(no )
2003-02-20
Trombomodulinanaloger for farmasoytisk anvendelse
DE602004028266D1
(de )
2010-09-02
Angiogene peptide und ihre verwendungen
Krajewski et al.
2003
Design and synthesis of dimeric HIV-1 integrase inhibitory peptides
MY126118A
(en )
2006-09-29
Somatostatin analogs for the treatment of cancer
ATE276273T1
(de )
2004-10-15
Vip-analoge
MY117747A
(en )
2004-07-31
Vasoactive intestinal peptide analogs
GB2411404A
(en )
2005-08-31
Biologically active peptide conjugates
AU2000265052A1
(en )
2002-02-13
Somatostatin analogs for the treatment of cancer
Su et al.
2022
Development of novel bone targeting peptide–drug conjugate of 13-aminomethyl-15-thiomatrine for osteoporosis therapy
ATE303401T1
(de )
2005-09-15
Fragmente des virus proteins 2 oder 3 des polyomavirus als fähren für wirkstoffe
Darwish et al.
2017
Efficient synthesis of CN2097 using in situ activation of sulfhydryl group
DE602004019141D1
(de )
2009-03-05
Isoleucyl-valyl-threonyl-asparaginyl-threonyl-threonin (ivtntt) enthaltende biologisch wirksame peptide
MY128151A
(en )
2007-01-31
Substance p analogs for the treatment of cancer
IL151211A0
(en )
2003-04-10
Compositions useful for regulating parkin gene activity
Prasad et al.
2007
Delivering multiple anticancer peptides as a single prodrug using lysyl‐lysine as a facile linker